US FDA approves J&J's immune disorder drug
The drug, which will be sold under the brand name Imaavy, was approved for patients with generalized myasthenia gravis - an immunity-related disorder that weakens the skeletal muscles, especially those in the eyes, mouth, throat and limbs.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The disorder affects about 10 to 20 individuals per 100,000 in the United States, according to government data.
J&J acquired the drug with its $6.5 billion buyout of autoimmune disease specialist Momenta in 2020.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
11 hours ago
- Reuters
US CDC trust shaken after shooting at Atlanta headquarters
NEW YORK, Aug 12 (Reuters) - Grappling with the aftermath of a shooting that killed a police officer and left nearly 100 shattered windows, leaders at the Centers for Disease Control and Prevention held virtual meetings with employees on Tuesday to rebuild trust at the agency's Atlanta headquarters. CDC employees who can work from home have not returned to the building, which government leaders toured on Monday. The Georgia Bureau of Investigation said on Tuesday during a press conference that nearly 200 rounds had struck six CDC buildings. A source briefed on the matter had previously told Reuters that 85 windows were broken and over 100 doors destroyed. During an hour-long call with staff of the National Center for Immunization and Respiratory Diseases, CDC Chief Medical Officer Dr. Debra Houry described the walk through the campus as devastating. "I saw glass everywhere…I saw glass outside your doors and the bullet holes by some of your doors,' Houry said, according to a copy of the recording reviewed by Reuters. During the call, employees described feelings of anger, desperation and isolation, and noted that they felt the extent of the shooting was not receiving the attention it deserved. Georgia investigators said they had found written documents in the shooter's home in which he expressed discontent with the COVID-19 vaccine. He died of a self-inflicted gunshot wound. Since being named U.S. Health and Human Services Secretary earlier this year, Robert F. Kennedy Jr. has targeted vaccine policy, and in May withdrew a federal recommendation for COVID shots for pregnant women and healthy children. Kennedy toured the site on Monday and said no one should face violence while working to protect the health of others. Dr. Demetre Daskalakis, director of the National Center for Immunization and Respiratory Diseases, defended the CDC as an agency whose goal is to keep the people it serves healthy and safe. 'People, through their words and actions, have created an environment where mistrust and dehumanization of public health and the people that do the lifesaving work have been used as weapons. It's our turn, as public health professionals, to demand that the trust that we have lost be rebuilt," he said during the call. A separate all-staff meeting that had been planned by CDC Director Susan Monarez became a virtual-only, short call on Tuesday without a question and answer session, according to a recording reviewed by Reuters.
Reuters
15 hours ago
- Reuters
India's Apollo Hospitals to double AI investments, beats profit estimate
HYDERABAD, Aug 12 (Reuters) - India's Apollo Hospitals Enterprise ( opens new tab plans to double its investment in artificial intelligence capabilities over the next two to three years, its CEO said, after the company beat first-quarter profit estimates on higher patient volume. The hospital chain already uses AI tools in diagnosis to read X-rays, scan reports and also in endoscopy - a medical procedure to examine the inside of the body using a camera, CEO Madhu Sasidhar told Reuters on Tuesday. Many large private hospital chains in India, like their western counterparts, are investing in AI capabilities to improve patient diagnosis and decisions related to medical procedures, among others uses. Apollo recently developed technology to read existing scan reports and predict the risk of liver fibrosis in the future, Sasidhar said. "We are also bringing some other new generation agentic AI-type tools," he said. He did not quantify the size of Apollo's existing investment in AI. Apollo, headquartered in the south Indian city of Chennai, partnered with Microsoft (MSFT.O), opens new tab earlier this year to develop AI-based tools to be used in healthcare. Some of them are in early stages of testing, Sasidhar said. Indian hospital chains such as Apollo and Manipal have also been increasing their bed count for a larger share of the market, including through acquisitions of smaller hospital operators. Apollo said it is on track to add 4,370 beds over the next 3-4 years through acquisition, new hospitals and expansion of existing facilities. Its overall bed capacity is currently more than 10,000. The company's consolidated net profit rose 41.8% to 4.33 billion rupees ($49.40 million) for April-June, beating estimates of 3.86 billion rupees, according to data compiled by LSEG. While its overall occupancy rate dipped from last year, in-patient volume grew 3% and average revenue per in-patient increased by 9%, according to Apollo. Quarterly total revenue rose 15% to 58.42 billion rupees, beating estimates of 57.44 billion rupees. The company said it expects double-digit revenue growth for the current financial year. ($1 = 87.6520 Indian rupees)
Reuters
21 hours ago
- Reuters
Cardinal Health to buy Solaris Health for $1.9 billion
Aug 12 (Reuters) - Drug distributor Cardinal Health (CAH.N), opens new tab said on Tuesday it would acquire Solaris Health for about $1.9 billion in cash.
